Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO)

76 filings reported holding MREO - Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares as of Q2 2022.
Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 73.6M shares of 791M outstanding shares and own 9.31% of the company stock.
Largest 10 shareholders include Rubric Capital Management LP (16.8M shares), Point72 Asset Management, L.P. (10M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (9.14M shares), ORBIMED ADVISORS LLC (7.11M shares), Rock Springs Capital Management LP (6.23M shares), Clearline Capital LP (3.06M shares), CITADEL ADVISORS LLC (2.76M shares), ORBIMED ADVISORS LLC (2.6M shares), BOXER CAPITAL, LLC (2.25M shares), and ALKEON CAPITAL MANAGEMENT LLC (1.74M shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.